influenza
viru
lead
caus
respiratori
diseas
unit
state
year
viru
normal
caus
mild
moder
diseas
hospit
death
occur
mani
case
sever
methodolog
use
detect
howev
problem
decreas
sensit
high
rate
falseneg
result
may
aris
crucial
need
effect
sampl
prepar
technolog
concentr
virus
low
abund
exclud
resid
analyt
may
interfer
detect
nanotrap
particl
hydrogel
particl
coupl
chemic
dye
affin
bait
bind
broad
rang
protein
virion
within
minut
minut
nanotrap
particl
concentr
low
abund
protein
virus
clinic
complex
matric
nanotrap
particl
reactiv
red
bait
concentr
numer
respiratori
virus
includ
variou
strain
subtyp
influenza
viru
coronaviru
respiratori
syncyti
viru
saliva
nasal
fluid
swab
specimen
nasal
aspir
detect
enhanc
coupl
plaqu
assay
qrtpcr
importantli
nanotrap
particl
effici
captur
concentr
multipl
viral
pathogen
coinfect
scenario
result
collect
demonstr
nanotrap
particl
import
tool
easili
integr
variou
detect
methodolog
influenza
commonli
refer
flu
seriou
respiratori
ill
caus
influenza
viru
negativesens
rna
viru
belong
famili
orthomyxovirida
viru
lead
season
epidem
well
global
pandem
unit
state
alon
viru
respons
death
hospit
year
season
epidem
occur
year
sever
pandem
occur
last
centuri
emerg
novel
strain
led
million
infect
million
death
worldwid
almost
centuri
later
appear
novel
strain
influenza
antigen
differ
previou
epidem
strain
yet
strike
similar
strain
still
concern
anoth
pandem
similar
spanish
flu
emerg
would
kill
million
worldwid
abil
influenza
viru
rapidli
evolv
result
vaccin
diagnost
assay
becom
potenti
ineffect
current
influenza
diagnost
capabl
limit
especi
detect
viru
low
viral
genom
copi
rapid
influenza
diagnost
test
ridt
detect
viru
less
thirti
minut
specimen
must
collect
earli
ill
possibl
hour
infect
high
viral
load
viral
antigen
level
present
studi
conduct
cdc
shown
ridt
sensit
compar
revers
transcript
polymeras
chain
reaction
rtpcr
assay
viral
cultur
lead
mani
fals
neg
result
larg
due
use
small
volum
sampl
assay
well
inclus
subsequ
interfer
high
abund
protein
complex
solut
nasopharyng
aspir
swab
sampl
therefor
definit
diagnosi
must
confirm
molecular
assay
viral
cultur
molecular
assay
rtpcr
abl
identifi
viral
rna
variou
strain
subtyp
influenza
howev
one
limit
detect
viral
rna
assay
indic
viabl
viru
ongo
influenza
viral
replic
respiratori
specimen
possibl
viral
cultur
propag
viru
cultur
facilit
analysi
viru
addit
method
use
compar
virul
antivir
resist
novel
circul
vaccin
strain
viru
therefor
substanti
need
accur
reliabl
sampl
prepar
methodolog
concentr
whole
viru
clinic
complex
specimen
increas
sensit
variou
diagnost
assay
influenza
respiratori
pathogen
nanotrap
particl
versatil
technolog
address
critic
diagnost
challeng
importantli
concentr
requir
coldchain
methodolog
nanotrap
particl
util
ambient
elev
temperatur
furthermor
particl
capabl
concentr
analyt
interest
larg
volum
complex
biolog
fluid
nasal
aspir
significantli
smaller
volum
low
ml
heart
nanotrap
technolog
base
particl
consist
network
crosslink
environmentallyrespons
polym
chain
function
affin
bait
facilit
analyt
captur
retent
versatil
nanotrap
particl
stem
varieti
affin
bait
immobil
onto
polym
matrix
date
nanotrap
particl
affin
dye
well
ligat
contain
cation
carboxyl
acid
sulfon
acid
group
gener
util
target
wide
rang
small
protein
peptid
analyt
captur
perform
nanotrap
particl
alter
custom
particl
architectur
addit
charg
inert
polym
shell
suit
intend
applic
novel
sampl
prepar
methodolog
util
concentr
enhanc
detect
infecti
diseas
protein
includ
lowabund
bacteri
antigen
outer
surfac
protein
ospa
use
diagnos
lyme
diseas
nucleoprotein
rift
valley
fever
viru
rvfv
nanotrap
particl
origin
design
specif
harvest
protein
small
molecul
recent
find
shafagati
et
al
shown
nanotrap
particl
also
use
captur
detect
virion
abil
nanotrap
particl
captur
virion
allow
sampl
analyz
numer
downstream
analyt
techniqu
protein
nucleic
acid
base
includ
standard
sandwich
elisa
later
flow
immunoassay
mass
spectroscopi
ms
techniqu
qrtpcr
assay
addit
rvfv
nanotrap
particl
shown
captur
virus
human
immunodefici
viru
hiv
venezuelan
equin
enceph
viru
veev
influenza
human
coronaviru
adenoviru
find
expand
determin
util
nanotrap
particl
respiratori
pathogen
detect
focus
primarili
influenza
viru
data
within
demonstr
novel
sampl
prepar
tool
coupl
plaqu
assay
qrtpcr
enhanc
viral
detect
vari
concentr
importantli
nanotrap
particl
captur
viru
variou
clinic
relev
matric
commonli
use
influenza
diagnost
includ
nasal
aspir
nasal
swab
saliva
lastli
nanotrap
captur
curtail
coinfect
scenario
variou
subtyp
strain
influenza
well
respiratori
virus
previou
publish
find
demonstr
sever
nanotrap
particl
capabl
captur
differ
virus
includ
respiratori
pathogen
influenza
order
quantit
determin
nanotrap
particl
abl
enhanc
detect
influenza
differ
type
nanotrap
particl
screen
viru
captur
enrich
perform
tabl
nanotrap
particl
incub
one
millilit
influenza
ia
pfu
ml
follow
captur
viral
rna
extract
amount
viru
captur
determin
use
qrtpcr
nanotrap
particl
success
captur
enrich
viru
nanotrap
particl
immobil
reactiv
red
dye
bait
provid
increas
detect
compar
sampl
without
nanotrap
particl
process
parallel
fig
enrich
capabl
confirm
strain
subtyp
influenza
anoth
influenza
strain
ia
influenza
b
test
without
ia
increas
detect
obtain
qrtpcr
fig
influenza
b
increas
detect
fig
ensur
whole
infecti
viru
captur
plaqu
assay
perform
panel
five
nanotrap
particl
incub
influenza
pellet
resuspend
media
plaqu
assay
perform
directli
nanotrapvir
mixtur
best
perform
provid
increas
detect
compar
nanotrap
control
fig
increas
detect
ia
fig
increas
detect
influenza
b
fig
obtain
collect
result
demonstr
infecti
virion
captur
enrich
use
increas
detect
qrtpcr
plaqu
assay
respect
achiev
influenza
captur
vari
depend
strain
subtyp
consist
enhanc
detect
variou
influenza
virus
plaqu
assay
qrtpcr
therefor
subsequ
experi
focus
evalu
enrich
perform
hypothes
nanotrap
particl
captur
viru
via
surfac
glycoprotein
test
hypothesi
hemagglutinin
ha
protein
incub
nanotrap
particl
captur
assess
western
blot
agreement
result
present
figur
effici
captur
ha
protein
ia
fig
abl
captur
littl
ngml
protein
yield
approxim
fold
enrich
compar
nt
control
fig
varieti
influenza
viru
subtyp
current
ha
subtyp
mutat
ha
protein
occur
quit
frequent
determin
nanotrap
particl
broadli
bind
ha
protein
protein
also
test
also
capabl
captur
enrich
protein
fig
result
indic
nanotrap
particl
bind
multipl
ha
protein
suggest
would
capabl
captur
influenza
virus
even
mutat
sever
specimen
use
influenza
diagnost
includ
nasopharyng
swab
nasopharyng
aspir
wash
deep
nasal
swab
throat
swab
saliva
swab
aspir
next
set
experi
set
demonstr
dilut
pfuml
pb
incub
ml
minut
room
temperatur
sampl
centrifug
unbound
materi
remov
pellet
wash
one
time
ml
distil
water
incub
addit
minut
sampl
centrifug
unbound
materi
discard
sampl
process
qrtpcr
panel
ac
plaqu
assay
panel
df
nt
sampl
ml
volum
process
parallel
reactiv
red
particl
enrich
viru
clinic
relev
matric
nanotrap
particl
outer
shell
surround
particl
core
previous
shown
function
well
serum
specul
incorpor
outer
shell
would
deter
viral
host
protein
nasal
fluid
saliva
bind
nanotrap
particl
therefor
parallel
two
addit
red
particl
differ
architectur
test
influenza
captur
tabl
contain
inert
polym
shell
surround
dyefunction
nanotrap
particl
core
particl
core
encapsul
within
charg
polym
shell
contain
sulfon
acid
group
captur
influenza
compar
one
anoth
salin
solut
contain
addit
host
protein
scenario
signific
differ
viral
rna
detect
among
three
reactiv
red
particl
type
fig
sinc
differ
captur
two
coreshel
particl
util
subsequ
experi
next
util
nasal
aspir
scenario
ia
spike
nasal
fluid
salin
solut
nanotrap
particl
incub
spike
sampl
interestingli
result
show
near
increas
detect
increas
detect
fig
suggest
addit
sulfon
acid
outer
shell
necessari
enhanc
influenza
captur
howev
captur
differ
two
particl
statist
differ
ia
captur
also
demonstr
nasal
fluid
second
donor
fig
captur
effici
test
swab
scenario
ia
spike
nasal
fluid
spike
sampl
ad
onto
swab
swab
suspend
salin
solut
swab
head
spun
remov
fluid
nanotrap
particl
ad
sampl
nanotrap
particl
abl
concentr
ia
statist
signific
differ
captur
two
nanotrap
particl
use
result
increas
detect
compar
nearli
increas
use
fig
lastli
nanotrap
particl
captur
saliva
perform
sputum
saliva
sampl
less
frequent
use
viral
diagnost
viral
yield
significantli
lower
type
specimen
howev
saliva
good
tool
detect
less
invas
easier
collect
patient
specul
sinc
compon
saliva
less
viscou
compar
nasal
fluid
sampl
saliva
sampl
would
easier
coupl
nanotrap
particl
ia
spike
saliva
evalu
effect
individu
saliva
protein
composit
nanotrap
particl
bind
influenza
viru
saliva
three
differ
donor
test
sampl
briefli
sonic
incub
provid
increas
detect
compar
nt
control
fig
importantli
figur
nanotrap
particl
enhanc
detect
influenza
hemagglutinin
protein
one
ml
histidinetag
hemagglutinin
protein
hisha
ia
mgml
incub
ml
minut
room
temperatur
b
ia
hisha
mgml
ngml
ngml
incub
ml
minut
room
temperatur
c
hisha
protein
mgml
incub
ml
minut
room
temperatur
hisha
protein
mgml
incub
ml
minut
room
temperatur
sampl
panel
ad
analyz
presenc
influenza
ha
western
blot
use
antibodi
direct
histidin
tag
control
sampl
hisha
mgml
andor
mgml
panel
c
nt
mgml
hisha
sampl
volum
ml
process
parallel
three
differ
batch
test
parallel
demonstr
similar
enrich
capabl
salin
saliva
fig
demonstr
nanotrap
particl
perform
consist
also
abl
captur
enrich
ia
neat
saliva
fig
collect
result
demonstr
coreonli
reactiv
red
particl
util
dramat
concentr
viru
increas
viral
detect
variou
clinic
matric
contain
numer
host
viral
protein
previous
mention
viral
shed
highest
hour
infect
influenza
dramat
increas
thereaft
sampl
collect
peak
time
fals
neg
result
like
occur
goal
next
set
experi
util
nanotrap
particl
concentr
viru
increas
lower
limit
detect
lod
viral
titer
virtual
undetect
ia
spike
salin
solut
nasal
fluid
saliva
variou
concentr
abil
captur
ia
analyz
qrtpcr
plaqu
assay
fig
everi
concentr
viru
test
three
fluid
capabl
captur
enrich
ia
notabl
pfuml
viral
rna
near
lod
qrtpcr
assay
howev
incub
ia
well
lod
panel
ac
likewis
ia
pfuml
saliva
undetect
without
nanotrap
particl
could
readili
detect
use
panel
c
plaqu
assay
nanotrap
particl
enhanc
detect
influenza
clinic
relev
matric
ia
dilut
pfuml
pb
incub
outer
shell
outer
shell
coat
vsa
sampl
process
qrtpcr
describ
figur
nt
sampl
ml
volum
process
parallel
b
nasal
wash
sampl
ia
dilut
pfuml
human
nasal
fluid
incub
nasal
swab
sampl
influenza
dilut
pfuml
human
nasal
fluid
spike
onto
flock
swab
swab
swirl
ml
pb
swab
head
cut
place
spin
basket
top
microcentrifug
tube
contain
sampl
centrifug
rpm
minut
swab
head
spin
basket
remov
sampl
transfer
new
microcentrifug
tube
ml
ad
sampl
sampl
process
qrtpcr
describ
figur
nt
sampl
ml
volum
process
parallel
statist
signific
panel
b
determin
oneway
anova
follow
tukey
multipl
comparison
test
pvalu
pvalu
pvalu
ns
signific
sampl
compar
nt
sampl
signific
comparison
indic
without
bracket
signific
comparison
indic
bracket
c
ia
dilut
pfuml
human
saliva
three
differ
donor
incub
sampl
process
qrtpcr
describ
figur
nt
sampl
ml
volum
process
parallel
ia
dilut
pfuml
human
saliva
singl
donor
incub
sampl
process
qrtpcr
describ
figur
nt
sampl
ml
volum
process
parallel
statist
signific
panel
c
determin
student
ttest
pvalu
pvalu
compar
nt
sampl
confirm
result
demonstr
consist
enrich
ia
virion
pfu
ml
salin
panel
pfuml
saliva
panel
e
result
demonstr
increas
detect
ia
high
low
viral
titer
previous
demonstr
nanotrap
particl
captur
respiratori
pathogen
adenoviru
dna
viru
coronaviru
anoth
rna
viru
enrich
capabl
nanotrap
particl
investig
variou
virus
caus
respiratori
ailment
respiratori
syncyti
viru
strain
rsv
coronaviru
strain
cov
two
envelop
rna
virus
test
without
nanotrap
particl
rsv
cov
five
nanotrap
particl
use
initi
influenza
screen
util
tabl
except
four
five
nanotrap
particl
captur
enrich
rsv
fig
five
nanotrap
particl
enrich
cov
fig
howev
best
perform
virus
provid
increas
detect
rsv
cov
respect
collect
result
demonstr
one
nanotrap
particl
use
captur
enrich
multipl
respiratori
pathogen
coinfect
influenza
respiratori
pathogen
rsv
cov
occur
especi
children
immunocompromis
adult
therefor
import
nanotrap
particl
enrich
viru
presenc
host
viral
analyt
also
presenc
infecti
pathogen
order
test
enrich
capabl
nanotrap
particl
util
dual
infect
scenario
multipl
respiratori
virus
hypothes
two
viru
type
compet
bind
figur
nanotrap
particl
enhanc
detect
influenza
high
low
titer
ac
ia
dilut
pfuml
pfuml
salin
panel
pfuml
pfuml
nasal
wash
panel
b
pfuml
pfuml
human
saliva
panel
c
incub
sampl
process
qrtpcr
describ
figur
nt
sampl
ml
volum
process
parallel
e
ia
dilut
pfuml
pfuml
salin
solut
panel
dilut
pfuml
pfuml
human
saliva
panel
e
incub
sampl
process
plaqu
assay
describ
figur
nt
sampl
ml
volum
process
parallel
statist
signific
panel
determin
student
ttest
pvalu
pvalu
pvalu
pvalu
ns
signific
compar
nt
sampl
dash
line
repres
lower
lod
assay
genom
copiesreact
ia
qrtpcr
pfuml
plaqu
assay
detect
nanotrap
particl
one
virus
may
therefor
decreas
test
hypothesi
mock
coinfect
scenario
perform
incub
sampl
contain
ia
ia
pfuml
salin
solut
sampl
signific
chang
detect
ia
presenc
ia
likewis
statist
signific
drop
ia
detect
presenc
ia
fig
next
mock
infect
scenario
ia
influenza
b
ib
virus
salin
solut
perform
sampl
incub
signific
chang
either
ia
ib
detect
fig
signific
chang
detect
nanotrap
sampl
presenc
multipl
virus
data
shown
coinfect
scenario
influenza
two
respiratori
virus
cov
rsv
perform
figur
nanotrap
particl
captur
respiratori
viral
pathogen
one
ml
respiratori
syncyti
viru
rsv
dilut
genom
ml
panel
coronaviru
cov
strain
dilut
genom
ml
panel
b
ad
ml
sampl
process
qrtpcr
describ
figur
nt
sampl
ml
volum
process
parallel
statist
signific
determin
oneway
anova
follow
tukey
multipl
comparison
test
pvalu
pvalu
pvalu
compar
nt
sampl
ns
signific
combin
two
virus
dilut
pfuml
pb
incub
c
ia
cov
strain
combin
two
virus
dilut
pfuml
ia
genom
cov
pb
incub
ia
rsv
strain
combin
two
virus
dilut
pfuml
ia
genom
rsv
pb
incub
sampl
process
analyz
qrt
pcr
viralspecif
primer
describ
figur
nt
sampl
ml
volum
process
parallel
fold
enrich
valu
sampl
shown
statist
signific
determin
student
ttest
pvalu
compar
nt
sampl
ns
signific
saliva
coinfect
scenario
ia
cov
incub
chang
detect
ia
howev
signific
drop
cov
detect
cov
alon
presenc
ia
fig
contrast
previou
experi
decreas
ia
detect
presenc
rsv
fall
ia
alon
coinfect
scenario
although
deem
statist
signific
decreas
rsv
detect
seen
presenc
ia
fig
signific
chang
detect
nt
sampl
data
shown
collect
result
indic
captur
concentr
varieti
differ
virus
coinfect
scenario
howev
enrich
remain
high
variou
virus
may
compet
bind
one
primari
benefit
nanotrap
particl
abil
captur
concentr
virus
howev
add
addit
sampl
process
step
diagnost
workflow
therefor
determin
captur
time
could
shorten
nanotrap
particl
incub
ia
variou
period
time
minut
viral
captur
assay
qrtpcr
fig
plaqu
assay
fig
five
minut
incub
time
provid
similar
level
enrich
observ
even
longest
incub
time
test
minut
result
demonstr
nanotrap
particl
rapidli
captur
influenza
viru
suggest
nanotrap
particl
workflow
could
reduc
least
minut
nanotrap
particl
tradit
use
captur
enrich
protein
sever
paper
shown
hydrogel
particl
enrich
numer
protein
insulin
myoglobin
pdgf
paper
dougla
et
al
demonstr
nanotrap
particl
dramat
concentr
lyme
diseas
antigen
urin
enhanc
detect
previous
undetect
concentr
recent
paper
publish
shafagati
et
al
demonstr
nanotrap
particl
also
util
enrich
protect
viral
antigen
rvfv
np
nanotrap
particl
also
use
captur
virion
captur
enrich
virion
rvfv
viral
pathogen
shown
sever
nanotrap
particl
importantli
viru
inactiv
heat
deterg
nanotrap
particl
incub
viral
nucleic
acid
still
detect
qrtpcr
previou
find
expand
upon
demonstr
nanotrap
particl
util
sampl
prepar
tool
concentr
influenza
respiratori
pathogen
first
goal
determin
compat
nanotrap
particl
influenza
viru
initi
nanotrap
particl
screen
reactiv
red
particl
identifi
top
candid
captur
strain
influenza
enrich
capabl
confirm
two
type
influenza
influenza
strain
influenza
b
result
suggest
despit
variat
ha
na
viral
glycoprotein
could
chang
bind
nanotrap
core
andor
bait
dramat
concentr
variou
strain
subtyp
influenza
exact
mechan
nanotrap
figur
nanotrap
particl
enrich
influenza
five
minut
incub
one
millilit
ia
dilut
pfu
ml
pb
incub
ml
minut
minut
room
temperatur
sampl
process
qrtpcr
panel
plaqu
assay
panel
b
describ
figur
nt
sampl
ml
volum
process
parallel
particl
specif
bind
influenza
viru
unknown
hypothes
nanotrap
particl
bind
viru
via
viru
surfac
glycoprotein
data
demonstr
captur
protein
support
hypothesi
previous
mention
contain
reactiv
red
dye
triazinederiv
textil
dye
neg
charg
commonli
use
protein
purif
via
affin
chromatographi
structur
triazin
dye
mimic
structur
substrat
bind
activ
site
differ
protein
therefor
abl
bind
broad
class
protein
enzym
possibl
triazin
dye
may
bind
molecul
involv
infect
mediat
viral
envelop
protein
specif
extracellular
portion
viral
glycoprotein
involv
viruscel
fusion
specul
chargebas
interact
could
play
role
bind
viru
host
cell
membran
sialic
acid
receptor
net
neg
charg
subunit
human
influenza
typic
posit
charg
neg
charg
anion
may
mimic
interact
host
viral
glycoprotein
therefor
facilit
bind
posit
charg
portion
ha
altern
positivelycharg
nanotrap
particl
could
bind
neg
charg
zone
neuraminidas
activ
site
previous
shown
captur
rvfv
hiv
vari
degre
howev
nanotrap
particl
contain
cibracon
blue
effect
captur
rvfv
hiv
suggest
rvfv
hiv
glycoprotein
greater
affin
cibracon
blue
compar
reactiv
red
affin
bait
order
investig
theori
futur
studi
util
electron
microscopi
determin
exact
mechan
nanotrap
particl
bind
virion
common
problem
diagnost
interfer
high
abund
host
protein
nasopharyng
saliva
sampl
contain
viscou
analyt
nonspecif
bind
antibodi
significantli
decreas
detect
furthermor
nasal
wash
collect
dramat
dilut
sampl
total
ml
collect
one
patient
howev
molecular
assay
ridt
allow
test
ml
sampl
nasal
aspir
experi
perform
util
ml
sampl
nanotrap
particl
slight
drop
detect
clinic
relev
matric
nasal
aspir
nasal
fluid
saliva
compar
salin
solut
signific
enrich
saliva
nasal
aspir
sampl
coreshel
varieti
test
determin
presenc
polymer
shell
could
improv
influenza
detect
clinic
relev
matric
contain
outer
polym
shell
function
sulfon
acid
group
provid
particl
neg
charg
sinc
signific
chang
captur
particl
contain
shell
versu
coreonli
particl
presenc
polym
shell
necessari
analyt
captur
specif
applic
virion
potenti
bind
host
protein
mucin
found
nasal
fluid
saliva
promiscu
natur
coreonli
particl
may
allow
proteinbound
virion
captur
nanotrap
particl
wherea
presenc
polym
shell
would
make
affin
bait
within
core
less
access
therebi
exclud
virusprotein
complex
bind
individu
virion
interestingli
use
coreonli
particl
mask
bind
site
observ
one
possibl
explan
observ
may
due
neg
charg
particl
result
studi
suggest
neg
charg
particl
capabl
repel
type
matrix
protein
bind
allow
target
analyt
interact
affin
dye
immobil
onto
core
particl
enrich
capabl
test
virus
caus
upper
lower
respiratori
ill
rsv
cov
envelop
rna
virus
increas
detect
result
strongli
suggest
nanotrap
particl
coreshel
andor
bait
interact
viral
glycoprotein
ha
protein
influenza
spike
protein
cov
result
demonstr
one
nanotrap
particl
coupl
multiplex
assay
allow
test
variou
pathogen
one
panel
therefor
data
within
provid
critic
inform
lay
groundwork
futur
studi
coupl
nanotrap
particl
clinic
sampl
previous
shown
nanotrap
particl
work
mix
infect
scenario
rvfv
hiv
coinfect
find
extend
respiratori
pathogen
specif
influenza
cov
rsv
promiscu
nanotrap
particl
allow
one
viru
analyt
captur
result
demonstr
featur
interfer
nanotrap
particl
enrich
capabl
dual
infect
scenario
featur
nanotrap
particl
favor
caus
infect
unknown
sever
virus
result
symptom
moreov
patient
may
coinfect
one
pathogen
time
infect
multipl
pathogen
rare
test
clinician
sever
studi
shown
dual
respiratori
viru
infect
occur
almost
case
lower
respiratori
tract
infect
especi
common
children
immunocompromis
system
one
studi
children
infect
one
type
respiratori
viru
case
children
coinfect
commonli
occur
rsv
anoth
respiratori
pathogen
influenza
although
rare
coinfect
influenza
b
type
also
seen
patient
also
import
note
secondari
bacteri
infect
streptococcu
pneumonia
oftentim
aris
infect
influenza
may
lead
seriou
superinfect
result
show
nanotrap
success
captur
detect
multipl
viral
pathogen
one
sampl
nanotrap
particl
util
captur
viru
publish
data
captur
bacteria
nanotrap
particl
sinc
bacteria
significantli
larger
virus
nanotrap
particl
larger
surfac
area
may
optim
captur
bacteria
futur
studi
investig
enrich
capabl
nanotrap
particl
bacteria
caus
respiratori
diseas
streptococcu
pneumonia
coupl
nanotrap
particl
technolog
multiplex
assay
test
multipl
pathogen
viral
bacteri
one
sampl
one
nanotrap
particl
data
present
herein
clearli
demonstr
signific
sampl
enrich
detect
respiratori
pathogen
complex
biolog
fluid
possibl
limit
nanotrap
technolog
addit
sampl
process
time
need
special
equip
eg
centrifug
concern
one
step
limit
addit
process
time
decreas
initi
incub
period
sampl
nanotrap
particl
littl
minut
incub
captur
enrich
influenza
viru
addit
magnet
version
nanotrap
particl
current
develop
order
improv
nanotrap
recoveri
process
follow
sampl
incub
well
shorten
sampl
process
time
incorpor
magnet
nanoparticl
polymer
network
nanotrap
particl
nanotrap
collect
separ
biofluid
sampl
via
magnet
decant
therebi
negat
need
special
equip
benchtop
centrifug
allow
nanotrap
use
resourcelimit
set
use
magnet
decant
separ
particl
biofluid
solut
also
decreas
sampl
process
time
minut
depend
workflow
requir
therebi
allow
target
analyt
captur
recov
detect
within
minut
less
second
limit
relat
avail
affin
bait
event
affin
bait
discontinu
supplier
would
result
limit
suppli
specif
nanotrap
type
decreas
avail
nanotrap
increas
cost
nanotrap
type
measur
counter
new
affin
bait
consist
test
determin
bait
substitut
gener
particl
captur
recoveri
perform
particl
limit
suppli
futur
project
also
investig
feasibl
extend
concept
downstream
methodolog
includ
later
flow
assay
lfa
enzymelink
immunoassay
elisa
beadbas
immunoassay
platform
use
detect
presenc
viral
antigen
influenza
np
nanotrap
particl
technolog
may
resolv
sensit
issu
common
problem
lfa
elisa
diagnost
viral
titer
often
fall
threshold
detect
lastli
nanotrap
particl
coupl
pointofcar
diagnost
devic
ridt
rapidli
minut
detect
variou
respiratori
pathogen
concept
expand
numer
emerg
infecti
diseas
provid
quick
safe
easytous
tool
diagnost
field
clinic
set
nanotrap
particl
provid
cere
nanosci
inc
manassa
va
nanotrap
environmentallyrespons
hydrogel
particl
base
crosslink
poli
nisopropylacrylamid
chain
nanotrap
particl
easili
customiz
engin
follow
featur
addit
main
core
particl
charg
inert
polym
shell
charg
function
group
carboxyl
acid
amin
function
group
andor
affin
dye
function
group
cibacron
blue
purpos
paper
five
differ
type
nanotrap
engin
suit
captur
enrich
target
analyt
seri
qaqc
test
conduct
newli
synthes
lotbatch
nanotrap
particl
includ
compar
analyt
captur
recoveri
perform
exist
lot
type
nanotrap
order
ensur
compar
perform
reduc
batchtobatch
variabl
prior
sampl
incub
ml
particl
centrifug
rpm
minut
nanotrap
storag
solut
discard
pellet
resuspend
ml
distil
ultrapur
water
sampl
centrifug
speed
time
supernat
discard
pellet
resuspend
ml
distil
ultrapur
water
final
concentr
mgml
madinedarbi
canin
kidney
mdck
cell
line
obtain
american
type
cultur
collect
atcc
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fb
penicillinstreptomycin
glutamax
supplement
dmem
cultur
humidifi
environ
contain
co
c
influenza
influenza
respiratori
syncyti
viru
strain
obtain
bei
resourc
catalog
number
respect
influenza
coronaviru
strain
obtain
influenza
reagent
resourc
catalog
number
respect
influenza
virus
propag
infect
mdck
cell
confluenc
moi
influenza
growth
media
igm
dmem
supplement
bovin
serum
albumin
nonessenti
amino
acid
lglutamin
penicillinstreptomycin
cell
cultur
medium
collect
cell
cytopath
effect
observ
typic
hour
postinfect
hpi
cell
cultur
medium
centrifug
rpm
minut
pellet
cellular
debri
cell
freevir
supernat
filter
use
mm
filter
viral
titer
determin
plaqu
assay
genom
copi
virus
determin
extract
viral
rna
cell
free
viral
supernat
perform
qrtpcr
viral
specif
primer
describ
nasal
fluid
obtain
lee
biosolut
human
saliva
obtain
bioreclamationivt
hmsaliva
sampl
sonic
use
misonix
ultrason
liquid
processor
seri
model
puls
w
puls
sampl
incub
ice
second
nasal
swab
obtain
binaxnow
influenza
b
kit
use
mockswab
scenario
accord
protocol
standard
cere
nanosci
ml
sampl
contain
viru
spike
either
igm
phosphat
buffer
salin
incub
ml
nanotrap
particl
mgml
minut
room
temperatur
sampl
centrifug
rpm
minut
supernat
contain
unbound
materi
discard
pellet
wash
one
time
ml
distil
ultrapur
water
incub
addit
minut
sampl
centrifug
rpm
minut
unbound
materi
discard
pellet
resuspend
appropri
buffer
mdck
cell
plate
well
plate
cell
ml
order
achiev
confluenc
nanotrap
particl
incub
pellet
resuspend
ml
igm
serial
dilut
perform
directli
resuspend
sampl
nt
sampl
control
viral
sampl
incub
nanotrap
particl
serial
dilut
perform
start
volum
ml
volum
ml
serial
dilut
ad
well
duplic
incub
minut
primari
overlay
known
cv
mixtur
consist
equal
part
agaros
distil
water
media
contain
emem
bsa
nonessenti
amino
acid
penicillinstreptomycin
sodium
pyruv
lglutamin
cv
mixtur
treat
mgml
trypsintpck
obtain
sigmaaldrich
volum
ml
cv
mixtur
ad
directli
well
cell
fix
formaldehyd
water
hpi
cell
stain
crystal
violet
ethanol
water
two
hour
crystal
violet
stain
wash
plaqu
form
count
determin
plaqu
form
unit
per
millilit
pfuml
nanotrap
particl
incub
pellet
resuspend
ml
distil
ultrapur
water
contain
carrier
rna
life
technolog
ratio
nt
sampl
volum
ml
process
parallel
volum
ml
trizol
ls
reagent
life
technolog
ad
cnt
nt
sampl
vortex
second
allow
incub
room
temperatur
minut
volum
ml
chloroform
ad
sampl
vortex
second
five
minut
incub
sampl
centrifug
c
speed
g
minut
colorless
upper
aqueou
phase
ml
remov
save
downstream
analysi
volum
ml
sampl
transfer
plate
rna
extract
perform
ambion
magmax
viral
rna
extract
kit
accord
manufactur
instruct
order
determin
number
viral
genom
copi
produc
qrtpcr
perform
use
either
superscript
iii
platinum
sybr
green
one
step
qrtpcr
kit
thermo
fisher
scientif
viral
specif
primer
rna
ultrasens
one
step
quantit
rtpcr
system
thermo
fisher
scientif
viral
specif
primer
probe
ia
rsv
cov
detect
sybr
green
pcr
accord
standard
protocol
use
ml
master
mix
contain
enzym
mix
reaction
mix
mm
forward
primer
mm
revers
primer
primer
use
includ
ia
forward
primer
att
act
gga
cac
tag
tag
agc
ia
revers
primer
gca
ttt
ctt
tcc
att
gcg
aa
cov
forward
primercgc
aag
aat
tca
gaa
cca
gag
cov
revers
primer
ggc
agt
cag
gtt
ctt
caa
caa
rsv
forward
primer
cat
cca
gca
aat
aca
cca
tcc
rsv
revers
primer
ttc
tgc
aca
tca
taa
tta
gga
gta
tca
sampl
heat
c
minut
hold
c
minut
hold
cycl
c
second
c
second
melt
curv
ad
end
reaction
ia
influenza
b
detect
rna
ultrasens
kit
use
accord
standard
protocol
use
ml
master
mix
contain
enzym
mix
reaction
mix
rox
refer
dye
mm
taqman
fluorogen
probe
mm
forward
primer
um
revers
primer
ad
ml
extract
rna
primer
probe
set
obtain
bei
resourc
sampl
heat
c
minut
c
minut
c
c
cycl
qrtpcr
analysi
perform
use
stepon
plu
real
time
pcr
system
appli
biosystem
viral
genom
copi
determin
compar
unknown
standard
curv
contain
known
rna
quantiti
extrapol
valu
rna
standard
made
extract
viral
rna
ia
ia
influenza
b
rsv
cov
viral
supernat
use
trizol
ls
reagent
quantifi
viral
rna
quantit
ribogreen
rna
assay
kit
thermofish
scientif
repres
standard
curv
qrtpcr
assay
shown
figur
histidinetag
hemagglutinin
ha
protein
influenza
influenza
influenza
agyrfalcon
influenza
anew
influenza
anetherland
obtain
influenza
reagent
resourc
catalog
number
respect
nanotrap
pellet
contain
captur
influenza
ha
protein
resuspend
ml
blue
lysi
buffer
contain
mixtur
tper
reagent
pierc
il
trisglycin
sd
sampl
buffer
novex
invitrogen
mm
dtt
proteas
phosphatas
inhibitor
cocktail
halt
cocktail
pierc
nanotrap
control
sampl
resuspend
ml
lysi
buffer
sampl
boil
min
nanotrap
sampl
centrifug
rpm
supernat
save
new
microcentrifug
tube
contain
ml
nupag
ld
buffer
invitrogen
sampl
centrifug
second
time
ensur
nanotrap
particl
pellet
supernat
separ
nupag
bistri
gel
invitrogen
transfer
nitrocellulos
pvdf
membran
c
overnight
membran
block
milk
pb
tween
pbst
hour
room
temperatur
histag
antibodi
cell
signal
technolog
dilut
milk
pbst
dilut
membran
wash
time
pbst
incub
secondari
hrpcoupl
antirabbit
antibodi
cell
signal
technolog
dilut
milk
hour
wash
time
pbst
minut
protein
gel
blot
visual
chemiluminesc
use
supersign
west
femto
maximum
sensit
substrat
kit
thermoscientif
biorad
molecular
imag
chemidoc
xr
system
biorad
statist
signific
determin
use
either
student
unpair
test
compar
mean
fold
enrich
valu
two
sampl
set
nt
control
oneway
anova
follow
tukey
multipl
comparison
test
differ
deem
statist
signific
pvalu
bl
ap
employ
cere
nanosci
coauthor
kkh
member
scientif
advisori
board
cere
nanosci
bl
sharehold
cere
nanosci
nanotrap
particl
use
studi
research
grade
provid
cere
nanosci
commerci
avail
product
alter
author
adher
polici
share
data
materi
